Gynecologic Cancer: Risk Factors, Interception and Prevention
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Epidemiology and Prevention".
Deadline for manuscript submissions: 20 May 2024 | Viewed by 830
Special Issue Editors
Interests: breast cancer prevention; ovarian cancer prevention; endometrial cancer prevention; cervical cancer prevention; HPV; prevention/interception clinical trials
Special Issue Information
Dear Colleagues,
Gynecologic cancers, including ovarian, endometrial and cervical cancers, account for approximately 100,000 new cases and over 30,000 deaths per year in the US. The prevention and interception of these cancers would greatly impact outcomes and significantly reduce mortality rates. For ovarian cancer, screening in the general population is not considered effective, and therefore most cases of this cancer are diagnosed at a late stage with a poor survival rate. Endometrial cancer incidence and mortality is markedly increasing in recent years, due in large part to increasing obesity rates. Cervical cancer has had the benefit of the availability of both screening and prevention. Equity in the dissemination and implementation of these prevention and screening methods is essential for early diagnosis and treatment. These opportunities and challenges related to the diagnosis and high mortality of these gynecologic cancers emphasize the importance of identifying women at higher risk for these cancer types, and providing prevention/interception interventions to decrease the incidence and improve outcomes.
Dr. Brandy Heckman-Stoddard
Dr. Goli Samimi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ovarian cancer
- endometrial cancer
- cervical cancer
- HPV
- cancer prevention
- gynecologic cancer risk reduction
- gynecologic cancer interception
- gynecologic cancer clinical trials
